The Cooper Companies Inc. (NYSE: COO) reported late on Thursday that fiscal third quarter income soared 37% as the bottom line was boosted by fatter margins and improved sales. Shares gained about 2.50% in extended trading hours as adjusted earnings edged past Street’s estimate. However, revenue missed expectation.
Category: Large Cap Growth Stocks
Major Movers on June 6; ASNA, QIWIQ, FRAN, PAY, CIEN
Shares of Ascena Retail Group Inc. (NASDAQ: ASNA) slumped about 10.30% by afternoon trade. The specialty retailer missed analysts’ estimates for the fiscal third quarter. Ascena Retail said on Wednesday that it earned (non-GAAP income) 26 cents a share compared to 34 cents a share, in the year earlier quarter. Net sales jumped 46% to $1.14 billion from $783 million, in the year-earlier quarter. Revenue was boosted by recently acquired Lane Bryant and Catherines businesses. Analysts surveyed by Thomson Reuters were expecting earnings of 30 cents a share on revenue of $1.17. The Company reiterated its full-year earnings guidance of $1.10 to $1.15 a share.
Continue reading Major Movers on June 6; ASNA, QIWIQ, FRAN, PAY, CIEN
Ciena Provides Upbeat Q3 Revenue Guidance (CIEN)
Networking equipment and software solutions provider, Ciena Corporation (NASDAQ: CIEN) said on Thursday that fiscal second quarter loss narrowed, aided by higher revenue and improved gross margin.
Continue reading Ciena Provides Upbeat Q3 Revenue Guidance (CIEN)
Endo Health to Cut Jobs, To Explore Strategic Options (ENDP)
Endo Health Solutions Inc. (NASDAQ: ENDP) said on Wednesday that it will slash its global staff by 15% and look for strategic alternatives to sale part of its business (HealthTronics), in order to focus on its core businesses. Continue reading Endo Health to Cut Jobs, To Explore Strategic Options (ENDP)
Major Movers on June 5; MFRM, CYBX, RES, AMBA, JNPR, BBBY
Shares of Mattress Firm Holding Corp. (NASDAQ: MFRM) jumped about 6.90% by afternoon trade. The bedding company, late last evening, said that fiscal first quarter profit rose, driven by a solid revenue growth and handed better-than-expected earnings as well as revenue. Mattress Firm also reaffirmed its full-year earnings and revenue outlook.
Continue reading Major Movers on June 5; MFRM, CYBX, RES, AMBA, JNPR, BBBY
Cyberonics Tops Q4 Estimates, Provides Upbeat Guidance for New Fiscal Year (CYBX)
Shares of Cyberonics Inc. (NASDAQ: CYBX) rallied on Wednesday after the medical device maker reported that fiscal fourth quarter income jumped 8.1%, driven by improved sales.
Continue reading Cyberonics Tops Q4 Estimates, Provides Upbeat Guidance for New Fiscal Year (CYBX)
Mattress Firm Tops Q1 Estimates, Reaffirms FY 2013 Outlook
Mattress Firm Holding Corp (NASDAQ: MFRM) reported late on Tuesday that fiscal first quarter income rose, aided by higher revenue. Both earnings and revenue edged past analysts’ consensus estimate.
Continue reading Mattress Firm Tops Q1 Estimates, Reaffirms FY 2013 Outlook
Major Movers on June 4; ABM, ET, DG, GIII, ULTA
Shares of ABM Industries Inc. (NYSE: ABM) jumped about 4% by afternoon trade after the integrated building security solutions provider reported late on Monday that fiscal second quarter income climbed 65%, thanks to recent acquisitions that boosted its top-line growth. For the fiscal second quarter, ABM reported adjusted/non-GAAP earnings of $20.2 million or 36 cents a share compared to $16.3 million or 30 cents a share, in the same quarter of last year. Analysts polled by Thomson Reuters were expecting earnings of 33 cents a share. Revenue jumped 11% to $1.17 billion from $1.06 billion but fell short of analysts’ consensus estimate for $1.18 billion.
Continue reading Major Movers on June 4; ABM, ET, DG, GIII, ULTA
Salesforce.com to Acquire ExactTarget in Deal Valued at $2.5 Billion (CRM, ET)
Salesforce.com Inc. (NYSE: CRM) announced on Tuesday that it has agreed to purchase marketing software maker ExactTarget Inc. (NYSE: ET) in a cash deal valued at $2.5 billion. Continue reading Salesforce.com to Acquire ExactTarget in Deal Valued at $2.5 Billion (CRM, ET)
Major Movers on June 3; CLVS, TSRO, MNKD, CBRL, FFIV
Shares of Clovis Oncology Inc. (NASDAQ: CLVS) catapulted about 120% by afternoon trade. The biopharmaceutical Company reported on Monday that its early stage clinical trials on a lung cancer treatment showed contraction in the size of tumor. The experimental treatment, dubbed as CO-1686, targets to cure non-small lung cancer (NSCLC) in patients with a transmutation in gene T790M.
Continue reading Major Movers on June 3; CLVS, TSRO, MNKD, CBRL, FFIV